Heterologous sarbecovirus receptor binding domains as scaffolds for SARS-CoV-2 receptor binding motif presentation.

SARS-CoV-2 coronavirus immune imprinting

Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
22 Aug 2023
Historique:
pubmed: 4 9 2023
medline: 4 9 2023
entrez: 4 9 2023
Statut: epublish

Résumé

Structure-guided rational immunogen design can generate optimized immunogens that elicit a desired humoral response. Design strategies often center upon targeting conserved sites on viral glycoproteins that will ultimately confer potent neutralization. For SARS-CoV-2 (SARS-2), the surface-exposed spike glycoprotein includes a broadly conserved portion, the receptor binding motif (RBM), that is required to engage the host cellular receptor, ACE2. Expanding humoral responses to this site may result in a more potently neutralizing antibody response against diverse sarbecoviruses. Here, we used a "resurfacing" approach and iterative design cycles to graft the SARS-2 RBM onto heterologous sarbecovirus scaffolds. The scaffolds were selected to vary the antigenic distance relative to SARS-2 to potentially focus responses to RBM. Multimerized versions of these immunogens elicited broad neutralization against sarbecoviruses in the context of preexisting SARS-2 immunity. These validated engineering approaches can help inform future immunogen design efforts for sarbecoviruses and are generally applicable to other viruses.

Identifiants

pubmed: 37662405
doi: 10.1101/2023.08.21.554179
pmc: PMC10473630
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI153098
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI155447
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007245
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007753
Pays : United States
Organisme : NIAID NIH HHS
ID : F30 AI160908
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI146779
Pays : United States
Organisme : NIDA NIH HHS
ID : DP2 DA040254
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI137057
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI168347
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI174875
Pays : United States

Déclaration de conflit d'intérêts

Declaration of interests: The authors have no competing interests to declare.

Auteurs

Blake M Hauser (BM)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, 02139, USA.

Maya Sangesland (M)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, 02139, USA.

Evan C Lam (EC)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, 02139, USA.

Kerri J St Denis (KJS)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, 02139, USA.

Maegan L Sheehan (ML)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, 02139, USA.

Mya L Vu (ML)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, 02139, USA.

Agnes H Cheng (AH)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, 02139, USA.

Alejandro B Balazs (AB)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, 02139, USA.

Daniel Lingwood (D)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, 02139, USA.

Aaron G Schmidt (AG)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, 02139, USA.
Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA.

Classifications MeSH